Recent news on Testim

Auxilium Pharma Says New Data Reveals Increase In Total ...  -  May 22, 2007
Trading Markets,The company said that total testosterone levels increased significantly in patients who switched to Auxilium's Testim 1% following suboptimal response to

Bentley Pharmaceuticals Reports $0.10 Diluted EPS on Record ...  -  May 1, 2007
PharmaLive.com (press release),Licensing and collaboration revenues increased $0.6 million to $2.3 million, primarily from increased royalties from Testim(R) sales.

Curfew for ASBO breach woman  -  Mar 30, 2007
Lancashire Evening Telegraph,Her barrister, Richard Bennett, said there were a number of testim-onials from people in authority at Styal prison, Cheshire, where she had been on remand,

Auxilium Pharmaceuticals to Present at the 32nd Annual Deutsche ...  -  Apr 24, 2007
PharmaLive.com (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.

Auxilium Pharmaceuticals to Present at the 32nd Annual Deutsche ...  -  Apr 24, 2007
PR Newswire (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.

Realtors(R) Urge Senate to Develop Comprehensive National Natural ...  -  Apr 11, 2007
PR Newswire (press release),WASHINGTON, April 11 /PRNewswire-USNewswire/ -- The National Association of Realtors(R), at two congressional hearings today, called upon the Senate to

Pillow talk  -  Apr 13, 2007
Telegraph.co.uk,Women can either have an implant, or get an easy-to-apply squirt of a gel called Testim, or TestroGel and voilà - they're up there pole dancing with the

Auxilium Pharmaceuticals to Announce First Quarter 2007 Results ...  -  Apr 10, 2007
PharmaLive.com (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.

Make way for Big Organic  -  Mar 29, 2007
New Statesman,..."The organic market in Britain is booming and Whole Foods Market's move is testim ony to this," says Soil Association spoke s woman Victoria Record.

Zacks Bull and Bear of the Day Highlights: CRA International ...  -  Mar 26, 2007
Business Wire (press release),The company’s only approved product is Testim, a 1% testosterone gel indicated for the treatment of hypogonadism. We are concerned that the termination of

Ipsen s Full Year 2006 Results (7º)  -  Mar 18, 2007
InfoBolsa,This corresponds to the full impairment of the net book value of the intangible asset related to Testim(R) rights. The performance of this product was below

Ipsen's earnings slips but prospects for 2007 are sound  -  Mar 20, 2007
Pharma Times (subscription),...to the anti-wrinkle treatment Reloxin/Dysport (botulinum toxin type A) and a 7.3 million-euro impairment charge relating to the testosterone gel Testim.

Ipsen's Full Year 2006 Results  -  Mar 18, 2007
American Digital Networks (press release),Impairment charges relating to Testim(R) amounted to a EUR 7.3 million expense in 2006. This corresponds to the full impairment of the net book value of the

Ipsen s Full Year 2006 Results (9º)  -  Mar 18, 2007
InfoBolsa,...paid to Inamed as described above, compared with an income of EUR 2.8 million a year ago; -- The impairment charge on Testim(R) of EUR 7.3 million.

Ipsen's Full Year 2006 Results  -  Mar 18, 2007
Genetic Engineering News (press release),...payment of EUR 8.4 million to Inamed for the recovery of all rights related to Reloxin(R)and a EUR 7.3 million impairment charge relating to Testim(R).

Auxilium Pharmaceuticals to Present at the Cowen and Company 27th ...  -  Mar 8, 2007
PharmaLive.com (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.

Bentley Pharmaceuticals Announces Fourth Quarter and Full Year ...  -  Mar 1, 2007
American Digital Networks (press release),The increase in licensing and collaboration revenues was primarily from royalties related to Testim(R) sales. Gross margins on net product sales for the

Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full ...  -  Feb 19, 2007
Drug Newswire (press release),..."Thanks to the exemplary efforts of our employees, 2006 was a very good year for Auxilium as we made significant progress in growing Testim(R) and continued

Auxilium Posts 4Q Loss, Besting Street  -  Feb 15, 2007
Houston Chronicle,The company said it grew its sales force for Testim and that royalty payments helped improve gross margins for the quarter to 74.5 percent from 70.1 percent

Paladin Reports Record 2006 Fourth Quarter and Year End Results  -  Feb 15, 2007
PharmaLive.com (press release),Paladin entered into an exclusive Canadian distribution agreement with Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) to market Testim®, a testosterone gel

Auxilium Announces Results from Phase III Trial that Show AA4500 ...  -  Feb 20, 2007
PR Newswire (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 190-person sales and marketing team.

TO THE POINT  -  Feb 15, 2007
Investor's Business Daily (subscription)It said strong sales for its topical testosterone gel Testim helped it beat views. It projected '07 sales of $88 mil-$92 mil, above views of $87.9 mil.

Roth 2007 OC Conference Presenter Profiles  -  Feb 16, 2007
American Digital Networks (press release),Auxilium markets Testim(R) 1%, its topical testosterone gel, for the treatment of hypogonadism through its approximately 180-person sales and marketing

Ipsen's Full Year 2006 Sales  -  Jan 31, 2007
Netherlands Corporate News (persbericht),Testim(R) - After launches in Germany, the United Kingdom, Benelux, Scandinavia and Spain in 2005 and in Portugal, Italy and Greece in 2006,

Investors Drive Bentley Higher  -  Jan 16, 2007
BusinessWeek...technology CPE-215, a way to improve drug absorption, to Auxilium Pharmaceuticals (AUXL) for use in its testosterone replacement therapy Testim.

Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement ...  -  Dec 12, 2006
Drug Newswire (press release),..."This agreement enables us to bring our innovative testosterone replacement product to Canadian patients and to continue to expand the reach of our Testim

Paladin and Auxilium Sign Exclusive Distribution Agreement for ...  -  Dec 12, 2006
Genetic Engineering News (press release),Testim(R) will benefit from Paladin's experience and knowledge of the testosterone replacement market and will further strengthen our growing urology

Auxilium in distribution deal with Paladin for Testim in Canada  -  Dec 12, 2006
ReutersO: Quote, Profile , Research) said it was in an exclusive agreement with Paladin Labs for the distribution of its testosterone replacement drug, Testim,

Auxilium, Paladin Enter Testim Pact  -  Dec 12, 2006
Houston Chronicle,Specialty drug maker Auxilium Pharmaceuticals Inc. said Tuesday it granted Paladin Labs Canadian distribution rights for its topical testosterone gel Testim

Auxilium, Paladin enter Testim pact  -  Dec 12, 2006
Hemscott,Testim is a topical gel used to treat hypogonadism, or a reduced or absent level of testosterone. The product was formerly distributed by Bayer AG's

Auxilium finds new Canada partner  -  Dec 12, 2006
Philadelphia Business Journal,Auxilium Pharmaceuticals Inc. entered into an exclusive agreement Tuesday that grants the Canadian distribution rights to Testim, its topical testosterone

Zacks Bull and Bear of the Day Highlights: Acusphere, Auxilium ...  -  Dec 13, 2006
Business Wire (press release),The company’s only approved product is Testim, a 1% testosterone gel indicated for the treatment of hypogonadism. We are concerned that the recent

Business news in brief  -  Dec 13, 2006
Philadelphia Inquirer,Auxilium Pharmaceuticals Inc. announced an agreement with a Canadian specialty-pharmaceutical firm to distribute its testosterone-replacement drug Testim in

Market Report -- In Play (WIRES)  -  Dec 12, 2006
MSN MoneyAuxilium Pharmaceuticals (AUXL) announces an exclusive agreement with Paladin Labs for the Canadian distribution rights to Testim, its topical testosterone

Investors Drive Bentley Higher  -  Dec 22, 2006
BusinessWeek...technology CPE-215, a way to improve drug absorption, to Auxilium Pharmaceuticals (AUXL) for use in its testosterone replacement therapy Testim.

(PRN) - Scott A. Pomeroy Named Chief Executive Officer of Local ...  -  Dec 12, 2006
Bolsamania.com,...(PRN) - Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada ... [+]

Auxilium Pharmaceuticals Amends Agreement with Cobra Biologics Ltd.  -  Nov 29, 2006
Drug Newswire (press release),Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 180-person sales and marketing team.

Bentley Pharmaceuticals Reports Third Quarter 2006 Results  Nov 2, 2006
...and increased licensing and collaboration revenues of approximately $828,000, primarily driven by increased royalty revenues from sales of Testim(R), the first ... -PharmaLive.com (press release), Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2006 ...  Oct 31, 2006
...progress during the quarter toward achieving our long term goals by taking control of Auxilium's main value drivers, our marketed product, Testim(R), and our ... -MSN Money Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2006 ...  Oct 31, 2006
...progress during the quarter toward achieving our long term goals by taking control of Auxilium's main value drivers, our marketed product, Testim®, and our ... -Yahoo! News (press release) Auxilium Pharmaceuticals to Present at the CIBC World Markets 17th ...  Nov 3, 2006
Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 180-person sales and marketing team. ... -Yahoo! News (press release) Ipsen's First Nine Months of 2006 Sales  Oct 29, 2006
In its third year of commercialisation, this product is increasingly contributing to the Group's growth. -- Testim(R) -- After launches in Germany, the United ... -Netherlands Corporate News (persbericht), Foro de Shell Security - Seguridad informática  Oct 26, 2006
Internationally: The annual in tessalon perles idence of aplastic anemia in Europe, as detailed in large, fo testim mal epidemiologic studies, is similar to ... -Shell Security, AA4500 Showed Marked Improvement In Patients With Peyronie's ...  Oct 26, 2006
Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium has four projects in clinical development. ... -Medical News Today (press release), Auxilium moves forward on one product, abandons another  Oct 18, 2006
...the treatment of hypogonadism. Auxilium's lead product, Testim, is a gel approved to treat the same condition. The company decided ... -Bizjournals.com, Business news in brief  Oct 19, 2006
Auxilium has one marketed product, a topical testosterone gel, Testim, that accounted for most of its $42.8 million in 2005 revenue. ... -Philadelphia Inquirer, Auxilium, Paladin Enter Testim Pact  -  12 Dec 2006
MSN MoneyPharmaceuticals Inc. said Tuesday it granted Paladin Labs Canadian distribution rights for its topical testosterone gel Testim. Financial ...

(PRN) - 13 Young Heroes Awarded For Their Angelic Community ...  -  12 Dec 2006
Bolsamania.com,...[+]. (PRN) - Auxilium Pharmaceuticals, Inc. Announces Distribution Agreement With Paladin Labs for Testim(R) in Canada ... [+. PRN ...

Auxilium Pharma Shares Fall on Downgrade  -  Nov 20, 2006
MSN Money...in the company's shares have increased by 200 percent year-to-date, Taylor wrote, as market share for Auxilium's low-testosterone treatment Testim has grown. ...

Auxilium Pharmaceuticals Amends Agreement with Cobra Biologics Ltd ...  -  Nov 29, 2006
Yahoo! News (press release)Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 180-person sales and marketing team. ...

Auxilium Pharmaceuticals Selected for Inclusion in the NASDAQ ...  -  Nov 14, 2006
Drug Newswire (press release),...reflects the increased awareness in the investment community of our successful progress in growing our marketed testosterone replacement gel, Testim(R), and in ...

Auxilium added to NASDAQ's biotech index  -  Nov 14, 2006
Philadelphia Business Journal,...reflects the increased awareness in the investment community of our successful progress in growing our marketed testosterone replacement gel, Testim, and in ...

Analyst Downgrades After Auxilium Completes Phase 3 Enrollment  -  Nov 21, 2006
Seeking Alpha,Almost all of his statements are positive. He cites that the company's low testosterone treatment, Testim, is capturing a larger market share. ...

Oscient agrees to acquire Antara rights from Reliant ...  Aug 23, 2006
...market and will be commercialized by Oscient's national sales force, which is marketing Factive (gemifloxacin mesylate) tablets and Testim 1% testosterone gel ... -Therapeutics Daily (subscription)

Bentley Pharmaceuticals Reports Second Quarter 2006 Results ...  Aug 3, 2006
...solid revenue growth fueled by an increase in non-USlicensing and manufacturing agreements and increased royalty revenuesfrom sales of Testim(R), the first ... -Finanzen.net

Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2006 ...  Aug 2, 2006
..."In the second quarter of 2006, Testim® achieved record net ... Testim received marketing approval in Canada for the treatment of patients with hypogonadism. ... -Yahoo! News

Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2006 ...  Aug 2, 2006
..."In the second quarter of 2006, Testim(R) achieved record net ... Testim received marketing approval in Canada for the treatment of patients with hypogonadism. ... -MSN Money

Bentley Pharmaceuticals Reports Second Quarter 2006 Results ...  Aug 3, 2006
...solid revenue growth fueled by an increase in non-US licensing and manufacturing agreements and increased royalty revenues from sales of Testim(R), the first ... -Business Wire

Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2006 ...  Aug 2, 2006
..."In the second quarter of 2006, Testim(R) achieved record net revenues and market share for ... patients with hypogonadism. Testim is now approved for sale in 16. ... -PharmaLive.com

Oscient Pharmaceuticals Hires Inder Kaul, MD, MPH as Vice ...  Aug 21, 2006
The Company is also promoting Auxilium Pharmaceuticals' TESTIM(r) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... -PharmaLive.com

Oscient Pharma 2Q Loss Widens  Aug 8, 2006
Revenue from the co-promotion with Auxilium Pharmaceuticals of Testim, a testosterone replacement gel, rose to $1.9 million from $370,000 last year. ... -Houston Chronicle

Oscient Pharmaceuticals Completes Acquisition of Cardiovascular ...  Aug 21, 2006
The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... -PharmaLive.com

Oscient buys rights to cholesterol drug for $78M  Jul 26, 2006
...sales infrastructure. Oscient also sells Factive, which treats chronic bronchitis and pneumonia, and Testim, a testosterone gel. As ... -Bizjournals.com

Waltham company buys rights to heart drug  Jul 25, 2006
...bronchitis or pneumonia. A third drug, Testim, which Oscient sells in partnership with Auxilium Pharmaceuticals Inc. of Norristown ... -MetroWest Daily News

Oscient Paying Reliant $78M For Cholesterol Drug In US  Jul 25, 2006
Testim, a testosterone gel from Malvern, Pa.-based Auxilium Pharmaceuticals Inc., also is promoted by the Oscient sales force to primary care physicians. ... -BioWorld Online

Cobra Extends Agreement to Manufacture AA4500 for Auxilium ...  Jul 19, 2006
Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 130-person sales and marketing team. ... -Oxfordshire Bioscience Network

Auxilium to start hypogonadism drug trial  Jun 29, 2006
The company said testosterone transmucosal film could complement Testim, its testosterone gel that is currently marketed for the treatment of hypogonadism. -Reuters

Auxilium Pharmaceuticals "buy," target price raised  Jun 23, 2006
...the company has announced robust late stage clinical data for one of its main pipeline programmes, leading to the creation of another value driver after Testim ... -newratings.com

Auxilium Appoints Armando Anido as Chief Executive Officer and ...  Jun 26, 2006
Thanks to her unwavering energy and entrepreneurial drive, we believe Auxilium is well positioned to grow its Testim® franchise in the testosterone ... -Yahoo! News

Oscient Pharmaceuticals Announces Meeting Date for FDA Advisory ...  Jun 28, 2006
The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... -Business Wire

Auxilium Pharmaceuticals Announces Start of US Phase III Pivotal ...  Jun 29, 2006
..."AA2600 represents a potential new formulation of testosterone that could complement Testim®, our 1% testosterone gel, that is currently marketed for the ... -Yahoo! News

Armstrong told doctor 'he had used EPO'  Jun 23, 2006
..."According to new testim-onies gathered from October 2005 to January 2006 by a court in Dallas, the seven-times Tour de France winner told an Indiana ... -Sydney Morning Herald

New leader announced by Auxilium  Jun 26, 2006
Thanks to her unwavering energy and entrepreneurial drive, we believe Auxilium is well-positioned to grow its Testim franchise in the testosterone replacement ... -Philadelphia Business Journal

Henwood resigns as Auxilium's chief executive  Jun 27, 2006
...topical testosterone gel. The product, Testim, accounted for most of Auxilium's $42.8 million in revenue last year. Auxilium's board ... -Philadelphia Inquirer

Auxilium Pharma Reveals Commencement Of Phase III Trial Of ...  Jun 29, 2006
Gerri Henwood, CEO, Auxilium said that AA2600 could complement Testim, the company's 1% testosterone gel, currently marked for the treatment of hypogonadism. ... -Trading Markets

Auxilium Pharmaceuticals' CEO to Resign  Jun 26, 2006
...entrepreneur.". In 1999, Henwood and two others founded Auxilium, which specializes in urology products and sells a testosterone gel, Testim. ... -International News Service



Oscient Pharmaceuticals Reports Financial Results for First ...  May 9, 2006
Oscient also recorded approximately $1.5 million in revenue from the Company's co-promotion agreement with Auxilium Pharmaceuticals for TESTIM(R) 1 ... - Genetic Engineering News

Auxilium Pharmaceuticals, Inc. Announces First Quarter 2006 ...  May 9, 2006
..."Testim delivered another ... Gross margin reflects the cost of product sold as well as royalty payments made to the Company's licensor on the sales of Testim. ... - Yahoo! News

Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 ...  May 11, 2006
...the past five years, Bentley's most advanced drug-delivery technology, CPE-215, has already led to the development of a marketed product, TESTIM, a topical ... - Genetic Engineering News

Webcast Alert: Oscient Pharmaceuticals Announces Date for Release ...  Apr 20, 2006
The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... - Genetic Engineering News

Auxilium Pharmaceuticals to Present at UBS Specialty ...  Apr 20, 2006
Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 120-person sales and marketing team. ... - Yahoo! News





Oscient Pharmaceuticals Announces $35 Million Private Placement ...  Apr 6, 2006
The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... - Genetic Engineering News

Oscient Pharmaceuticals' FACTIVE Tablets Subject of Poster ...  Apr 4, 2006
...patients. The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US. ... - International News Service

Bentley Pharmaceuticals Reports Financial Results for Full Year ...  Mar 8, 2006
And the growth of our royalty revenues reflects the strong sales of Testim(R), a testosterone gel containing our CPE-215(R) permeation platform technology ... - Genetic Engineering News

Auxilium Pharmaceuticals to Present at CIBC Investor Conference  Mar 30, 2006
Auxilium markets Testim® 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 120-person sales and marketing team. ... - Yahoo! News

Business news in brief  Mar 8, 2006
Auxilium Pharmaceuticals Inc., which makes a topical testosterone gel called Testim, reported a net loss of $11 million on net revenue of $12.9 million for the ... - Philadelphia Inquirer



Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year ...  Feb 16, 2006
Auxilium markets Testim(R) 1%, a topical testosterone gel, for the treatment of hypogonadism through its approximately 120 person sales and marketing team. ... - PR Newswire,

Roth Capital Partners 18th Annual Growth Stock Conference ...  Feb 17, 2006
...the past five years, Bentley's most advanced drug-delivery technology, CPE-215, has already led to the development of a marketed product, TESTIM, a topical ... - Genetic Engineering News,

Webcast Alert: Oscient Pharmaceuticals to Present at BIO CEO & ...  09 Feb 2006
The Company is also promoting Auxilium Pharmaceuticals' TESTIM(R) 1% testosterone gel to primary care physicians in the US Oscient has a novel antibiotic ... - Genetic Engineering News

Oscient Pharmaceuticals Provides Preliminary Revenues for Fourth ...  Jan 9, 2006
...from its lead product, FACTIVE(R) (gemifloxacin mesylate) tablets, and the remainder primarily from the Company's co-promotion partnership for TESTIM(R)1 ... - Genetic Engineering News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional